Collaboration to develop proprietory selection norepinephrine and serotonin reuptake inhibitor for depression and central nervous system disorders.
Filed under: Analgesics, Article, Autoimmune Diseases, Awareness, British, CBS News, CFS, Canada, Central Nervous System, Chronic Fatigue, Chronic Fatigue Syndrome, Chronic Pain Disorders, Europe, FM, FMS, FMS Global News, FSS, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia Blogs, Fibromyalgia News, Fibromyalgia News Australia, Fibromyalgia News Belgium, Fibromyalgia News Denmark, Fibromyalgia News Deutschland, Fibromyalgia News France, Fibromyalgia News India, Fibromyalgia News Israel, Fibromyalgia News Italy, Fibromyalgia News Japan, Fibromyalgia News Jerusalem, Fibromyalgia News Korea, Fibromyalgia News Norway, Fibromyalgia News Southeast Asia, Fibromyalgia News Spain, Fibromyalgia News Turkey, Fibromyalgia News UK, Fibromyalgia News Wisconsin, Fibromyalgia Press Releases, Fibromyalia News Germany, Finland, Functional Somatic Syndrome, Global News, Health, Health Canada, Jeanne Hambleton, Journalist UK, London UK, London UK Feed, Medical Journals, Montreal, News, News Australia, News Belgium, News Canada, News Denmark, News France, News India, News Ireland, News Israel, News Italy, News Japan, News Jerusalem, News Korea, News Montreal, News Nigeria, News Norway, News Quebec, News Saskatchewan, News Scotland, News Southeast Asia, News Spain, News Sweden, News Toronto, News Turkey, News UK, News Wisconsin, Ontario, Ontario Research and Development, Ottawa, Ottawa City Feed, Pain Management, Pain Management Clinic, Portugal, Quality of Life, Quebec, RSS, RSS Feeds, Research, Science, Seattle, Spain, Stockholm, Support Groups, Surrey and Sussex, Swedish, Switzerland, Syndromes, Tenderpoints, The Netherlands., Toronto, Toronto City Feed, US, USA, University of Michigan, Virginia, Washington D.C. City Feed, Washington DC, World, World News, World Wide, Worldwide | Leave a Comment »
